Alphatec Holdings, Inc.

Alphatec Holdings, Inc. designs and develops medical technologies for spinal disorders treatment. It manufactures implants and instruments through third-party suppliers. The company offers various products, including imaging systems, alignment tools, and robotics-based intra-operative systems. Products also include spinal implants, fixation systems, and biologics such as bone grafts and tissue barriers. Sales are made through a network of independent agents and direct sales representatives. Founded in 1990, the company is headquartered in Carlsbad, California.

Overview

Sector

Medical Devices

Target Price

0.0 USD

Current Price

16.5 USD

Potential

-100%

Strengths

No significant strengths identified based on the analyzed metrics.

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Price to book ratio (100.00) is significantly higher than the sector mean (13.90).
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (100.00) is higher than the sector mean.
The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (2.97%).
EV/EBIT (100.00) is significantly higher than the sector mean.
EBITDA Margin (0.00%) appears relatively low.

Indicator	Value
PER	100.0
EV/EBITDA	100.0
Price/Free Cash Flow'	100.0
ROIC	-%
Net Debt/EBITDA	100.0

Alphatec Holdings, Inc.

Overview

Strengths

Weaknesses

Key Financial Data